Recent Advances in Theranostic Applications of Nanomaterials in Cancer.


Journal

Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487

Informations de publication

Date de publication:
2022
Historique:
received: 17 03 2021
accepted: 16 07 2021
pubmed: 18 9 2021
medline: 29 3 2022
entrez: 17 9 2021
Statut: ppublish

Résumé

Early detection and accurate monitoring are two critical factors affecting the outcome of anticancer therapy. However, both these factors are affected by the limitations of conventional approaches of diagnosis and treatment. Nanomedicine has progressively offered a scientific solution in improved delivery and better diagnosis of various cancers, thus providing a targeted treatment approach. With the advances in the field, simultaneous delivery and diagnosis are becoming a reality. The present manuscript discusses various drug delivery challenges, provides the scope for theranostic nanomaterials in the diagnosis and treatment of cancer. The clinical and translational potential of theranostic nanomedicine and the future directions for further research are also presented in the manuscript.

Identifiants

pubmed: 34530703
pii: CPD-EPUB-117970
doi: 10.2174/1381612827666210916140627
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-150

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Faraha Ahmed (F)

Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi-110062, India.

Mohammad Ahmed Khan (MA)

Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi-110062, India.

Nafis Haider (N)

Department of Pharmaceutics, Prince Sultan Military College of Health Sciences, Dhahran 34313, Kingdom of Saudi Arabia.

Mohammad Zaki Ahmad (MZ)

Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Kingdom of Saudi Arabia.

Javed Ahmad (J)

Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Kingdom of Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH